PT615754E - Formas solidas de administracao oral de libertacao controlada flupertina - Google Patents
Formas solidas de administracao oral de libertacao controlada flupertinaInfo
- Publication number
- PT615754E PT615754E PT94103292T PT94103292T PT615754E PT 615754 E PT615754 E PT 615754E PT 94103292 T PT94103292 T PT 94103292T PT 94103292 T PT94103292 T PT 94103292T PT 615754 E PT615754 E PT 615754E
- Authority
- PT
- Portugal
- Prior art keywords
- flupirtine
- release
- flupertine
- oral administration
- solid forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4308572 | 1993-03-18 | ||
DE4319649A DE4319649A1 (de) | 1993-03-18 | 1993-06-14 | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe |
Publications (1)
Publication Number | Publication Date |
---|---|
PT615754E true PT615754E (pt) | 2002-11-29 |
Family
ID=25924047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT94103292T PT615754E (pt) | 1993-03-18 | 1994-03-04 | Formas solidas de administracao oral de libertacao controlada flupertina |
Country Status (9)
Country | Link |
---|---|
US (1) | US6667058B1 (pt) |
EP (1) | EP0615754B1 (pt) |
JP (1) | JP3844517B2 (pt) |
AT (1) | ATE220321T1 (pt) |
BR (1) | BR9401199A (pt) |
DE (2) | DE4319649A1 (pt) |
DK (1) | DK0615754T3 (pt) |
ES (1) | ES2179832T3 (pt) |
PT (1) | PT615754E (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4443175A1 (de) * | 1994-12-05 | 1996-06-13 | Jenapharm Gmbh | Neue pulsatile Arzneiform |
DE10224086A1 (de) * | 2002-05-31 | 2003-12-11 | Bayer Ag | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
DE10312346A1 (de) * | 2003-03-20 | 2004-09-30 | Bayer Healthcare Ag | Kontrolliertes Freisetzungssystem |
DE10327674A1 (de) | 2003-06-20 | 2005-01-05 | Awd.Pharma Gmbh & Co. Kg | Injizierbare Darreichungsform von Flupirtin |
DE10328260A1 (de) * | 2003-06-23 | 2005-01-27 | Schmidt, K.-G., Dr. med. | Flupirtine-Präparat |
EP1688141A1 (en) | 2005-01-31 | 2006-08-09 | elbion AG | The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome |
DE102005054610B4 (de) * | 2005-11-08 | 2010-06-10 | Awd.Pharma Gmbh & Co. Kg | Flupirtin enthaltende Arzneimittelzubereitung mit kontrollierter Wirkstofffreisetzung |
CA2645855C (en) | 2006-03-16 | 2015-02-03 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
US20080279930A1 (en) * | 2007-05-07 | 2008-11-13 | Bernd Terhaag | Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof |
EA019038B1 (ru) | 2008-06-09 | 2013-12-30 | Авд. Фарма Гмбх Унд Ко. Кг | Сульфонатные соли 2-амино-3-карбэтоксиамино-6-(4-фторбензил-амино)пиридина |
EP2346826A2 (en) | 2008-06-09 | 2011-07-27 | AWD.pharma GmbH & Co.KG | Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine |
DE102010030053A1 (de) | 2010-06-14 | 2011-12-15 | Awd.Pharma Gmbh & Co.Kg | Injizierbare Darreichungsform von Flupirtin |
US8287903B2 (en) | 2011-02-15 | 2012-10-16 | Tris Pharma Inc | Orally effective methylphenidate extended release powder and aqueous suspension product |
CN102764257B (zh) * | 2011-10-21 | 2013-09-25 | 四川百利药业有限责任公司 | 一种马来酸氟吡汀缓释片剂 |
EP2819658A2 (de) * | 2012-03-02 | 2015-01-07 | MEDA Pharma GmbH & Co. KG | Pharmazeutische formulierung enthaltend flupirtin |
CA2880456A1 (en) | 2012-08-15 | 2014-02-20 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
CN104083335B (zh) * | 2013-07-31 | 2015-11-11 | 成都苑东药业有限公司 | 一种马来酸氟吡汀胶囊组合物及其制备方法 |
US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
US11918689B1 (en) | 2020-07-28 | 2024-03-05 | Tris Pharma Inc | Liquid clonidine extended release composition |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3896108A (en) * | 1974-05-10 | 1975-07-22 | Hercules Inc | Carboxyalkyl modified ethyl cellulose |
HU187215B (en) * | 1983-01-26 | 1985-11-28 | Egyt Gyogyszervegyeszeti Gyar | Method for producing pharmaceutical product of high actor content and prolonged effect |
DE3665538D1 (en) * | 1985-01-23 | 1989-10-19 | Asta Pharma Ag | Synergistic combination of flupirtin and non-steroidal anti-phlogistics |
EP0193056B1 (de) * | 1985-02-23 | 1989-06-07 | ASTA Pharma Aktiengesellschaft | Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika |
FI855016A (fi) * | 1985-06-28 | 1986-12-29 | Degussa | Synergistisk kombination av flupirtin och 4-acetamido-fenol. |
FR2585246A1 (fr) * | 1985-07-26 | 1987-01-30 | Cortial | Procede d'obtention de formes pharmaceutiques solides a liberation prolongee |
GB8519310D0 (en) * | 1985-07-31 | 1985-09-04 | Zyma Sa | Granular active substances |
US5238686A (en) * | 1986-03-27 | 1993-08-24 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
US4959219A (en) * | 1988-08-15 | 1990-09-25 | Fisons Corporation | Coating barriers comprising ethyl cellulose |
US5229131A (en) * | 1990-02-05 | 1993-07-20 | University Of Michigan | Pulsatile drug delivery system |
IN172468B (pt) * | 1990-07-14 | 1993-08-14 | Asta Medica Ag | |
DK0560092T3 (da) * | 1992-03-11 | 1998-08-10 | Asta Medica Ag | Tabletter, granulater og pellets med højt indholdaf aktivstoffer til højkoncentrerede, faste administreringsformer |
-
1993
- 1993-06-14 DE DE4319649A patent/DE4319649A1/de not_active Withdrawn
-
1994
- 1994-03-04 ES ES94103292T patent/ES2179832T3/es not_active Expired - Lifetime
- 1994-03-04 EP EP94103292A patent/EP0615754B1/de not_active Expired - Lifetime
- 1994-03-04 AT AT94103292T patent/ATE220321T1/de active
- 1994-03-04 DK DK94103292T patent/DK0615754T3/da active
- 1994-03-04 PT PT94103292T patent/PT615754E/pt unknown
- 1994-03-04 DE DE59410151T patent/DE59410151D1/de not_active Expired - Lifetime
- 1994-03-17 US US08/212,578 patent/US6667058B1/en not_active Expired - Lifetime
- 1994-03-17 JP JP04711194A patent/JP3844517B2/ja not_active Expired - Lifetime
- 1994-03-17 BR BR9401199A patent/BR9401199A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP3844517B2 (ja) | 2006-11-15 |
EP0615754B1 (de) | 2002-07-10 |
DK0615754T3 (da) | 2002-10-28 |
JPH06298647A (ja) | 1994-10-25 |
BR9401199A (pt) | 1994-10-18 |
EP0615754A1 (de) | 1994-09-21 |
ATE220321T1 (de) | 2002-07-15 |
DE59410151D1 (de) | 2002-08-14 |
US6667058B1 (en) | 2003-12-23 |
ES2179832T3 (es) | 2003-02-01 |
DE4319649A1 (de) | 1994-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT615754E (pt) | Formas solidas de administracao oral de libertacao controlada flupertina | |
DK0438249T3 (da) | Naproxenformulering med styret absorption til indgivelse en gang daglig | |
ATE76747T1 (de) | Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen. | |
GR1003711B (el) | Μεθοδος δια την παρασκευη φαρμακευτικων συνθεσεων δια συστηματικην διαδερμικην χορηγησιν. | |
DE59102210D1 (de) | Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus. | |
IL95691A0 (en) | Thienylcarboxylates of amino alcohols,their preparation and pharmaceutical compositions containing them | |
DE69403656T2 (de) | Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph | |
ATE58292T1 (de) | L-dopa enthaltendes arzneimittel. | |
ATE179602T1 (de) | Stabilisierte, feste pharmazeutische zubereitung, die dextromethorphan phenylpropanolamine und coffein enthält | |
AU3318389A (en) | Azelastine-containing medicaments with controlled release of the active substance | |
AU563762B2 (en) | S-adenosyl-l-methionine salts preparation | |
GR890100833A (en) | Process for the preparation of a compound with gastric inhibitopy effect | |
GB2021409A (en) | Pharmaceutical composition | |
EP0351876A3 (en) | Composition for potentiating vaccination effect | |
ES2033512T3 (es) | Composicion antiastenica, su procedimiento de preparacion y su utilizacion. | |
DK0560207T3 (da) | Præparat til oral anvendelse baseret på ibuprofen | |
DK493887A (da) | Buccal formulering |